The Latest Breaking News from Obesity

Exclusive: Poll findings prompt calls for ministers to impose sugar tax-style levy on companies to combat obesity

As Congress pushes for Medicare to cover anti-obesity drugs, puzzlement remains about who should get them, for how long, and at what price.

Tirzepatide, a drug for diabetes and obesity, has sent the 148-year-old pharma giant on a wild ride. It’s now the ninth most valuable company in the world.

Evidence has grown that school BMI screenings aren’t helpful and can even be harmful. Why do they persist?

Research suggests large fat cells predict weight loss, while small fat cells may lead to weight gain over time.‌ New insights into how fat cell size influences weight dynamics in a study presented to the European Congress on Obesity. ‌

Most diseases can’t be treated solely with lifestyle intervention, and obesity is no exception.

“BMI doesn't tell you what I can do, what I do on the field, how much muscle I have,” Ilona Maher said. The post Olympic Athlete Has The Perfect Response About BMI After Viewers Mock Her Weight first appeared on Bored Panda.

Pfizer's stock shows signs of a potential rebound, buoyed by recent pipeline successes in hemophilia and obesity treatments, an attractive 5% dividend yield, and a rock-bottom valuation. This makes it an appealing dividend stock for value and income investors as the drug giant prepares to report earnings.

Recent reports reveal North Korean leader Kim Jong Un's health issues due to obesity, raising concerns about succession.